More importantly, cardiac-targeted expression of STK35 exerts a marked beneficial action, including increasing cardiac vascular density, attenuating cardiac remodeling, and ameliorating cardiac function in a mouse model of diabetes mellitus. The gene discussed is STK35; the disease is diabetes mellitus.